The area of pharmaceutical pricing and reimbursement continues to be complex, controversial and varied. The primary focus for the conference will be pharmaceutical pricing and reimbursement in the US. With the current price regulation proposals in the US among the state and federal governments, including reference pricing, which has been used in Europe, we will welcome some European presenters on Day Two to look at options employed by other nations and how they have or have not worked. The convergence of US and European pricing will be addressed and we will look at how companies use differential global pricing strategies to promote equitable access to products worldwide.
Due to the significant amount of government action in the last year revolving around initiatives by individual states to regulate pricing in various ways, we will review the litigation in this area. The government is raising questions about the manufacturers reported "average wholesale prices", which are used to determine payments under the Medicare and Medicaid programmers - a roundtable discussion with a mixed panel will provide some interesting, if differing points of view on this subject.

Key Issues to be discussed:


Health economics as an input to pricing: does cost effectiveness matter?

A Government perspective on Medicare and Medicaid

How will the increasing focus on drug budget control, both HMO and government affect US pricing?

State price controlling mechanisms

How do you develop the value of products early in development to support optimal pricing?

The economic forces driving convergence of prices in Europe and what effect is this having on the rest of the world? Is a global strategy achievable or desirable?

The controversy over pharmaceutical prices and a look at lowering prices versus innovation

Global Pricing Strategies for global brands - integration of US, Canadian and European pricing strategies

The relationship between R and D investment and pricing

New product strategy and research techniques for the US market

Impact of International Price Referencing on Global Pricing Strategies for pharmaceuticals

Access Conferences have just successfully run the 3rd European Pharmaceutical Pricing Conference in London and are now looking forward to welcoming you to THE US Pharmaceutical Pricing event of the year. Come along and listen to, learn from and discuss issues with leading practitioners, academics, government bodies, consultants and others in the industry. This two-day meeting will provide a timely forum to bring attendees up to date with the cutting edge issues and challenges affecting pricing strategy in the US.

$1,895 per delegate Discounts: $1,645 per delegate if booked before 23rd August 2002